Merus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.

About MRUS

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. 

CEO
Sven Ante Lundberg
CEOSven Ante Lundberg
Employees
260
Employees260
Headquarters
Utrecht, Utrecht
HeadquartersUtrecht, Utrecht
Founded
2003
Founded2003
Employees
260
Employees260

MRUS Key Statistics

Market cap
7.28B
Market cap7.28B
Price-Earnings ratio
-18.02
Price-Earnings ratio-18.02
Dividend yield
Dividend yield
Average volume
1.48M
Average volume1.48M
High today
$96.17
High today$96.17
Low today
$95.88
Low today$95.88
Open price
$96.17
Open price$96.17
Volume
1.51M
Volume1.51M
52 Week high
$96.28
52 Week high$96.28
52 Week low
$33.19
52 Week low$33.19

Stock Snapshot

Merus(MRUS) stock is priced at $95.94, giving the company a market capitalization of 7.28B. It carries a P/E multiple of -18.02.

As of 2025-12-01, Merus(MRUS) stock has fluctuated between $95.88 and $96.17. The current price stands at $95.94, placing the stock +0.1% above today's low and -0.2% off the high.

Merus(MRUS) shares are trading with a volume of 1.51M, against a daily average of 1.48M.

During the past year, Merus(MRUS) stock moved between $33.19 at its lowest and $96.28 at its peak.

During the past year, Merus(MRUS) stock moved between $33.19 at its lowest and $96.28 at its peak.

MRUS News

Simply Wall St 5d
Merus: Evaluating the Biotech’s Valuation After a 127% Year-to-Date Surge

Merus (MRUS) has quietly posted some interesting long-term returns, raising questions about how this biotech stock’s value stacks up after recent moves. Despite...

Merus: Evaluating the Biotech’s Valuation After a 127% Year-to-Date Surge

Analyst ratings

88%

of 17 ratings
Buy
11.8%
Hold
88.2%
Sell
0%

People also own

Based on the portfolios of people who own MRUS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.